Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
OptimizeRx Corporation - SIC # 8081 -
Ticker
Exchange
SIC #
Website
Latest Ticker
OPRX
Nasdaq
8081
www.optimizerx.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for OptimizeRx Corporation
OptimizeRx First Quarter 2025 Earnings: Beats Expectations
- May 14th, 2025 11:18 am
Q1 2025 OptimizeRx Corp Earnings Call
- May 13th, 2025 12:08 pm
OptimizeRx Corp (OPRX) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Shifts
- May 13th, 2025 7:08 am
OptimizeRx Corp. (OPRX) Beats Q1 Earnings and Revenue Estimates
- May 12th, 2025 9:35 pm
OptimizeRx Reports First Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance
- May 12th, 2025 8:05 pm
OptimizeRx Releases 2025 Environmental, Social, and Governance (ESG) Report
- May 1st, 2025 8:05 pm
OptimizeRx Sets First Quarter 2025 Conference Call for May 12, 2025, at 4:30 p.m. ET
- Apr 23rd, 2025 11:30 am
OptimizeRx Corporation Announces Plan for Additional Board of Directors Refreshment
- Apr 18th, 2025 8:15 pm
OptimizeRx Corporation (NASDAQ:OPRX) is favoured by institutional owners who hold 59% of the company
- Mar 30th, 2025 1:21 pm
Why OptimizeRx Corp. (OPRX) Soared Last Week?
- Mar 17th, 2025 12:31 pm
OptimizeRx Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags
- Mar 13th, 2025 10:48 am
OptimizeRx Corp (OPRX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Margin Expansion
- Mar 13th, 2025 7:03 am
Q4 2024 OptimizeRx Corp Earnings Call
- Mar 13th, 2025 5:25 am
OptimizeRx Corp. (OPRX) Q4 Earnings and Revenues Beat Estimates
- Mar 12th, 2025 12:45 pm
OptimizeRx Reports Strong Fourth Quarter and Full Year 2024 Financial Results
- Mar 12th, 2025 11:30 am
OptimizeRx Corporation Confirms Receipt of Notice of Director Nominations
- Mar 11th, 2025 11:30 am
OptimizeRx Corporation Appoints Stephen Silvestro as Chief Executive Officer
- Mar 10th, 2025 11:30 am
What Does OptimizeRx Corporation's (NASDAQ:OPRX) Share Price Indicate?
- Mar 5th, 2025 10:50 am
OptimizeRx Sets Fourth Quarter and Full Year 2024 Financial Results Conference Call for March 12, 2025, at 8:30 a.m. ET
- Feb 27th, 2025 12:30 pm
One OptimizeRx Insider Raised Their Stake In The Previous Year
- Feb 12th, 2025 10:22 am
Scroll